Novel type of specialized transduction for CTXφ or its satellite phage RS1 mediated by filamentous phage VGJφ in Vibrio cholerae
Novel type of specialized transduction for CTXφ or its satellite phage RS1 mediated by filamentous phage VGJφ in Vibrio cholerae
复制标题
DOI:
10.1128/jb.185.24.7231-7240.2003
复制
发表时间:
2003-12-01
影响因子:
3.2
通讯作者:
Fando, R
中科院分区:
文献类型:
--
作者:
Campos, J;Martínez, E;Fando, R
The main virulence factor of Vibrio cholerae, the cholera toxin, is encoded by the ctxAB operon, which is contained in the genome of the lysogenic filamentous phage CTXphi. This phage transmits ctxAB genes between V cholerae bacterial populations that express toxin-coregulated pilus (TCP), the CTXphi( receptor. In investigating new forms of ctxAB transmission, we found that V cholerae filamentous phage VGJphi, which uses the mannose-sensitive hemagglutinin (MSHA) pilus as a receptor, transmits CTXphi or its satellite phage RS1 by an efficient and highly specific TCP-independent mechanism. This is a novel type of specialized transduction consisting in the site-specific cointegration of VGJphi and CTXphi (or RS1) replicative forms to produce a single hybrid molecule, which generates a single-stranded DNA hybrid genome that is packaged into hybrid viral particles designated HybPphi (for the VGJphi/CTXphi hybrid) and HybRSphi (for the VGJphi/RS1 hybrid). The hybrid phages replicate by using the VGJphi replicating functions and use the VGJphi capsid, retaining the ability to infect via MSHA. The hybrid phages infect most tested strains more efficiently than CTXphi, even under in vitro optimal conditions for TCP expression. Infection and lysogenization with HybPphi revert the V. cholerae live attenuated vaccine strain 1333 to virulence. Our results reinforce that TCP is not indispensable for the acquisition of CTXphi. Thus, we discuss an alternative to the current accepted evolutionary model for the emergence of new toxigenic strains of V. cholerae and the importance of our findings for the development of an environmentally safer live attenuated cholera vaccine.